Document:

Exhibit 10.14

 Exhibit 10.14 
 FORM 
 OF 
 OPTICAL CABLE CORPORATION 
 2005 STOCK INCENTIVE PLAN 
 FY              RESTRICTED STOCK AWARD 
 (Operational Performance Vesting) 
 [Note: This
Form of Restricted Stock Award may change from time to time at the direction of the Compensation Committee of the Board of Directors or the Board of Directors.] 
  

									
	 GRANTED TO
	 	 GRANT DATE
	 	 NUMBER OF
 SHARES GRANTED
	 	 PRICE PER
 SHARE
	 	 SOCIAL
 SECURITY
 NUMBER

					
	 _______________
	 	_______________	 	_______________	 	N/A	 	_______________
			
	 	 	 GRANT NUMBER
	 	 VESTING AND RESTRICTION LAPSE
SCHEDULE*

			
		 	_______________	 	Shares granted hereunder will vest, in accordance with and subject in all respects to the provisions of Sections 3 and 4 below, on _______ of each year (each such date, a
“Vesting Date”), with the first Vesting Date being ___________, 20__ and the last Vesting Date being ___________, 20__ .

	*	Fractional shares shall be carried over to the last vesting period 

 OPTICAL CABLE CORPORATION and its successors and assigns (the “Company”) hereby grants to
                     (the “Participant”) effective
                     (the “Grant Date”), a Restricted Stock Award (the “Award”), pursuant to its 2005 Stock
Incentive Plan that is provided along herewith (the “Plan”), covering the above stated number of shares (the “Restricted Shares”) of common stock of the Company (“Common Stock”). 
 The Chief Executive Officer proposed this Award and recommended its approval to the Compensation Committee of the Board of Directors of the Company (the
“Compensation Committee”), and the Compensation Committee, pursuant to the terms of the Plan, granted the Award to the Participant. 
 The Plan is administered by the Compensation Committee, or alternatively and as appropriate, the Board of Directors (in either case, the “Committee”). Any controversy that arises concerning this Award or the Plan shall be resolved
by the Committee as it deems proper, and any decision of the Committee shall be final and conclusive. 
 The terms of the Plan are hereby
incorporated into this Award by this reference. In the case of any conflict between the Plan and this Award, the terms of the Plan shall control. Capitalized terms not defined in this Award shall have the meaning assigned to such terms in the Plan.

 Now, therefore, in consideration of the foregoing and the mutual covenants hereinafter set forth: 
 1. The Company hereby grants to the Participant an Award covering the Restricted Shares, subject to the terms and conditions of this Award and the Plan.

  

 1 

 2. Unless otherwise determined by the Committee [or unless as otherwise provided in Section 4(b)
below], the Award will vest, and the restrictions applicable to Restricted Shares shall lapse (with the shares no longer subject to the restrictions set forth herein being referred to as “Unrestricted Shares”), in accordance with
Section 3 below. Except as otherwise provided in the Plan or in Section 4 below or otherwise determined by the Committee, the Participant must be employed at all times from the Grant Date through a Vesting Date in order for part of this
Award to vest on such Vesting Date, and the restrictions on that portion of the Restricted Shares to lapse. 
 3. On each Vesting Date, a
portion of the Award shall vest in accordance with the performance criteria set forth on Exhibit A attached hereto. In any event, Participant shall not be entitled to receive more than the total number of Restricted Shares shown as the “Number
of Shares Granted” set forth at the top of this document. Any Restricted Shares covered by the Award that have not vested in accordance herewith or pursuant to Section 4 below on or before
            , 20    , shall be irrevocably forfeited. 
 4. a. Unless otherwise determined by the Committee [or unless as otherwise provided in Section 4(b) below], in the event that Participant’s employment with the Company and/or any subsidiaries terminates before the Award is fully
vested and the restrictions on all of the Restricted Shares have lapsed, Participant will, upon the date of Participant’s termination of employment (as reasonably fixed and determined by the Company), forfeit the remainder of the Restricted
Shares and the Company will be the owner of such remaining Restricted Shares and will have the right, without further action by Participant, to transfer such remaining Restricted Shares into its name. 
 [b. If a Triggering Event (as defined in Section 4 (c) below) occurs while Participant is employed by the Company (or if Participant’s
employment is terminated during the pendency of an event that, if consummated, would lead to a Triggering Event), but before the Award is fully vested and the restrictions applicable to all of the Restricted Shares have lapsed, then the date upon
which the Triggering Event (or the date of the termination of Participant’s employment if Participant’s employment is terminated during the pendency of an event that, if consummated, would lead to a Triggering Event) occurs will be the
Vesting Date with respect to the unvested portion of the Award, and such unvested portion of the Award shall thereupon immediately vest and all restrictions on the remaining Restricted Shares shall lapse.] [Note: This paragraph is applicable to
grants for executive officers only] 
 [c. For purposes of this Award, a “Triggering Event” occurs if, after the date of this
Award, (i) any person, including a “group” as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, becomes the owner or beneficial owner of Company securities having 50% or more of the combined voting power of the
then outstanding Company securities that may be cast for the election of the Company’s directors; or (ii) as the direct or indirect result of, or in connection with, a tender or exchange offer, a merger or other business combination, a
sale of assets, a contested election of directors, or any combination of these events, the persons who were directors of the Company before such events cease to constitute a majority of the Corporation’s Board, or any successor’s board,
within three years of the last of such transactions. For purposes of this Award, a Triggering Event occurs on the date on which an event described in (i) or (ii) occurs. If a Triggering Event occurs on account of a series of transactions
or events, the Triggering Event occurs on the date of the last of such transactions or events. ] [Note: This paragraph is applicable to grants for executive officers only] 
 5. Participant will not sell, transfer, pledge, hypothecate or otherwise dispose of any Restricted Shares (or any interest in such shares) prior to the
Vesting Date as to which the restrictions applicable to such shares lapse. 
 6. Prior to a Vesting Date, the Company will, at its option,
reflect Participant’s ownership of the Restricted Shares in book-entry form with the Company’s transfer agent or through the issuance of one or more stock certificates. If the Company elects to reflect ownership through the issuance of
stock certificates, such certificates will be held in escrow with the Corporate Secretary of the Company in accordance with the provisions of this Award and the Plan. Subject to terms of this Award and the Plan, Participant will have all rights of a
shareholder with respect to the Restricted Shares while they are held in escrow or in book-entry form, including, without limitation, the right to vote the Restricted Shares and receive any cash dividends declared on such shares. If, from time to
time prior to the date that the Award is fully vested and the restrictions on all of the Restricted Shares have lapsed, there is (i) any stock dividend, stock split or other change in the Restricted Shares, or (ii) any merger or sale of
all or substantially all of the assets or other acquisition of the Company, any and all new, substituted or additional 

  

 2 

 
securities to which Participant is entitled by reason of his ownership of the Restricted Shares shall be held on his behalf by the Company in book-entry form
or through the issuance of one or more stock certificates and held in escrow pursuant to this section until vesting pursuant to the schedule applicable to the underlying Restricted Shares, at which time all restrictions shall lapse. 
 7. As described in the Plan, in the event of certain corporate transactions or other actions or events, the Committee may take such actions with respect
to this Award as it deems appropriate and consistent with the Plan. 
 8. Participant understands that Participant (and not the Company) is
responsible for any tax liability that may arise as a result of the transaction contemplated by this Award. Participant understands that Section 83 of the Internal Revenue Code of 1986, as amended (the “Code”) taxes as ordinary income
the difference between the amount paid for the Restricted Shares and the fair market value of the Restricted Shares as of the date the restrictions on such shares lapse. Participant understands that Participant may elect to be taxed at the time of
the Award, rather than when the restrictions lapse, by filing an election under Section 83(b) of the Code with the Internal Revenue Service within 30 days from the Grant Date. 
 9. As a condition of accepting this Award, Participant agrees to make arrangements for the payment of withholding of income taxes and employment taxes
upon the vesting of the Award and the lapse of restrictions on the Restricted Shares. Until adequate arrangements have been made, certificates representing Unrestricted Shares will not be issued to Participant. Participant may satisfy applicable
withholding taxes by any manner permitted by the Plan, subject to the consent of the Committee, including, (i) delivering a sufficient number of shares of already owned Common Stock (which have been owned by Participant for more than six
(6) months), and/or (ii) having the Company retain a sufficient number of shares from the distribution to be made to Participant. 
 10. The fact that the Participant has been granted this Award will not affect or qualify the right of the Company or a subsidiary to terminate the Participant’s employment at any time. 
 11. If any provision of this Award should be deemed void or unenforceable for any reason, it shall be severed from the remainder of the agreement, which
shall otherwise remain in full force and effect. 
 12. The Company may, in its discretion, delay delivery of a certificate required upon
vesting of the Award until (i) the admission of such shares to list on any stock exchange (including NASDAQ) on which the Common Stock may then be listed, (ii) the completion of any registration or other qualification of such shares under
any state or federal law, ruling, or regulation of any governmental regulatory body that the Company shall, in its sole discretion, determine if necessary or advisable, and (iii) the Company shall have been advised by counsel that it has
complied with all applicable legal requirements. 
 13. Any notice to be given under the terms of this Award shall be addressed to Optical
Cable Corporation, to the attention of the Chief Financial Officer, 5290 Concourse Drive, Roanoke, VA 24019, and any notice to be given to Participant or to his or her personal representative shall be addressed to him or her at the address set forth
below or to such other address as either party may, hereafter, designate in writing to the other. Notices shall be deemed to have been duly given if mailed, postage prepaid, addressed as aforesaid. 
 14. You may accept this Award, subject to the registration and listing of the shares issueable under the Plan, by signing and returning the enclosed copy
of this Award. Your signature will also evidence your agreement to the terms and conditions set forth herein and to which this Award is subject. 
 15. Along with this Award, you hereby acknowledge receipt of a copy of the Plan and the Prospectus for the Plan. Also, if you have previously been granted an award under the Plan, you hereby acknowledge that you have received all of the
reports, proxy statements and other communications generally distributed to the holders of the Company’s securities since the date(s) of such grant(s) and no later than the times of such distributions. 
 [16. Note: With respect to any individual Award, Committee may insert required retention periods for shares received pursuant to an Award, applicable
even after such shares are Unrestricted Shares.] [Note: With respect to any individual Award, Committee may condition receipt of shares under this Award on other events or conditions.] 
  

 3 

 (Signature Page Follows) 
 IN WITNESS WHEREOF, the Company has caused this Award to be signed, as of the Grant Date shown above. 
  

			
	 OPTICAL CABLE CORPORATION

		
	By:	 	  
		 	

 I hereby acknowledge receipt of this Award, the Plan, and the Prospectus for the Plan, and I
agree to conform to all terms and conditions of this Award and the Plan. 
  

					
			
	   	 		 	   
	 Name
	 		 	 Date

			
	   	 		 	   
	 Signature
	 		 	 Address

  

 4Second Amendment to Credit Agreement

 Exhibit 10.01 
 SECOND AMENDMENT TO CREDIT AGREEMENT 
 THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this
“Amendment”) is entered into as of June 14, 2006, by and between NATUS MEDICAL INCORPORATED, a Delaware corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”).

 RECITALS 
 WHEREAS, Borrower
is currently indebted to Bank pursuant to the terms and conditions of that certain Credit Agreement, dated as of January 4, 2006 (as amended, modified and/or supplemented from time to time, the “Credit Agreement”), by and
between Borrower and Bank. 
 WHEREAS, Borrower has requested that Bank permit Borrower to make certain changes in the terms and conditions
set forth in the Credit Agreement. 
 WHEREAS, Bank has agreed to Borrower’s request to amend the Credit Agreement upon the terms and
conditions of this Amendment. 
 NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree that the Credit Agreement shall be amended as follows: 
 1. Definitions. Each capitalized term used but not
otherwise defined herein has the meaning assigned to it in the Credit Agreement. 
 2. Amendments to Credit Agreement. The Credit
Agreement is hereby amended as follows: 
 (a) Article I, Definitions, is hereby amended by adding to such
Article, in correct alphabetic order, each of the following new definitions: 
 “Adjusted Total Liabilities”
means, as of any date of determination, Total Liabilities as of such date of determination minus the Bio-Logic DTL as of such date of determination plus the Natus DTA as of such date of determination. 
 “Adjusted Tangible Net Worth” means, as of any date of determination, Tangible Net Worth as of such date of determination
plus Ten Million Two Hundred Thousand Dollars ($10,200,000.00) minus the greater of (i) zero and (ii) the difference between the Base Date Bio-logic DTL and the Bio-logic DTL as of such date of determination. 

 “Base Date Bio-logic DTL” means the deferred tax liability arising as a
direct result of Borrower’s merger with Bio-logic (but solely to the extent any such deferred tax liability arose as a direct result of Borrower’s merger with Bio-logic), as reflected in Borrower’s balance sheet immediately upon the
effectiveness of Borrower’s merger with Bio-logic. 
 “Base Date Natus DTA” means that portion of the
deferred tax asset of Borrower for which the valuation allowance was released as a direct result of Borrower’s merger with Bio-logic (but solely to the extent any such deferred tax asset was reinstated (or a corresponding valuation allowance
released) by Borrower as a direct result of Borrower’s merger with Bio-logic), as reflected in Borrower’s balance sheet immediately upon the effectiveness of Borrower’s merger with Bio-logic. 
 “Bio-logic DTL” means, as of any date of determination, the deferred tax liability reported in Borrower’s balance
sheet that relates solely to the Base Date Bio-logic DTL (such amount being the Base Date Bio-logic DTL, as adjusted since the original entry in Borrower’s financial statements for the Base Date Bio-logic DTL resulting from Borrower’s
merger with Bio-logic). 
 “Natus DTA” means, as of any date of determination, the deferred tax asset
reported in Borrower’s balance sheet that relates solely to the Base Date Natus DTA (such amount being the Base Date Natus DTA, as adjusted since the original entry in Borrower’s financial statements for the Base Date Natus DTA resulting
from Borrower’s merger with Bio-logic). 
 (b) Article I, Definitions, is hereby amended by amending and
restating in their entirety each of the following definitions in such Article: 
 “Tangible Net Worth” means,
as of any date of determination, the aggregate of Borrower’s total stockholders’ equity less any intangible assets of Borrower. 
 “Total Liabilities” means, as of any date of determination, the aggregate of the current liabilities and non-current liabilities of Borrower. 
 (c) Article V, Affirmative Covenants, is hereby amended by amending and restating in its entirety Section 5.9(b) as
follows: 
 (b) Adjusted Total Liabilities divided by Adjusted Tangible Net Worth not greater than, (i) on or before
September 30, 2006, 1.50 to 1.00, and (ii) after September 30, 2006, 1.00 to 1.00, in all cases as of each fiscal quarter end of Borrower. 
  

 - 2 - 

 (d) Article V, Affirmative Covenants, is hereby amended by inserting,
immediately after Section 5.3(e) thereof, new Section 5.3(f) as follows: 
 (f) not later than 45 days after and as
of the end of each fiscal quarter, a certificate of the chief financial officer of Borrower, substantially in the form of Exhibit B hereto stating (i) whether or not such officer has knowledge of the occurrence of any Event of
Default, or any condition, event or act which with the giving of notice or the passage of time or both would constitute an Event of Default, in either case not theretofore reported and remedied and, if so, stating in reasonable detail the facts with
respect thereto, and (ii) all relevant facts in reasonable detail to evidence, and the computations as to, whether or not Borrower is compliance with the financial covenants contained in Section 5.9 hereof. 
 (e) The Compliance Certificate attached hereto as Exhibit B shall become Exhibit B to the Credit Agreement and all
references in the Credit Agreement to “Exhibit B” shall be interpreted as references to Exhibit B hereto. 
 3.
Conditions Precedent. The obligation of Bank to grant the changes provided under this Amendment is subject to the fulfillment to Bank’s satisfaction of all of the following conditions by not later than June 16, 2006: 
 (a) Documentation. Bank shall have received, in form and substance satisfactory to Bank, each of the following, duly executed:

  

	 	i.	this Amendment; 

  

	 	ii.	the Guarantor’s Consent and Reaffirmation attached hereto; and 

  

	 	iii.	such other documents as Bank may require under any other Section of this Amendment. 

 (b) No Default. No default or Event of Default under the Credit Agreement shall have occurred and be continuing (except for any
such event that would exist but for the execution and delivery of this Amendment). 
 (c) Amendment Fee. Payment in
full by Borrower, in immediately available funds, of a non-refundable waiver fee of $3,500.00. 
 4. Fees and Expenses. Borrower shall
pay to Bank immediately upon demand the full amount of all payments, advances, charges, costs and expenses, including reasonable attorneys’ fees (to include outside counsel fees and all allocated costs of Bank’s in-house counsel), expended
or incurred by Bank in connection with the negotiation and preparation of this Amendment. 
 5. Interpretation. Except as specifically
provided herein, all terms and conditions of the Credit Agreement remain in full force and effect, without waiver or modification. This Amendment and the Credit Agreement shall be read together, as one document. The Recitals hereto, including the
terms defined therein, are incorporated herein by this reference and acknowledged by Borrower to be true, correct and accurate. 
  

 - 3 - 

 6. Representations, Warranties and Covenants. Effective as of the date of this Amendment, Borrower
hereby: (i) remakes all representations and warranties contained in the Credit Agreement; (ii) reaffirms all covenants set forth in the Credit Agreement; (iii) certifies that the corporate borrowing resolution, secretary’s
certificate and certificate of incumbency delivered in connection with the Credit Agreement are true and correct; and (iv) confirms that no default or Event of Default under the Credit Agreement has occurred and is continuing (except for any
such event that would exist but for the execution and delivery of this Amendment). 
 7. Further Assurances. Borrower will make,
execute, endorse, acknowledge, and deliver any agreements, documents, or instruments, and take any and all other actions, as may from time to time be reasonably requested by Bank to perfect and maintain the validity and priority of the liens and
security interests granted to Bank pursuant to the Credit Agreement and the other Loan Documents and to effect, confirm, or further assure or protect and preserve the interests, rights, and remedies of Bank under the Credit Agreement and the other
Loan Documents. 
 8. Counterparts. This Amendment may be executed in any number of counterparts, each of which when executed and
delivered shall be deemed to be an original, and all of which when taken together shall constitute one and the same Amendment. Each of the parties hereto understands and agrees that this Amendment (and any other document required herein) may be
delivered by any party hereto and thereto either in the form of an executed original or an executed original sent by facsimile transmission to be followed promptly by delivery of a hard copy original, and that receipt by Bank of a facsimile
transmitted document purportedly bearing the signature of a party shall bind such party with the same force and effect as the delivery of a hard copy original. Any failure by Bank to receive the hard copy executed original of such document shall not
diminish the binding effect of receipt of the facsimile transmitted executed original of such document of the party whose hard copy page was not received by Bank. 
 9. Governing Law. This Amendment shall be construed in accordance with the laws of the state of California, except to the extent Bank has greater rights or remedies under United States federal law, whether as a
national bank or otherwise, in which case such choice of California law shall not be deemed to deprive Bank of such rights and remedies as may be available under United States federal law. 
 * * * * * * * 
  

 - 4 - 

 IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Credit Agreement to be
executed as of the day and year first written above. 
  

							
	BORROWER:	 	BANK:
		
	NATUS MEDICAL INCORPORATED	 	WELLS FARGO BANK, NATIONAL ASSOCIATION
				
	By:	 	 /s/ STEVEN J. MURPHY
	 	By:	 	 /s/ MICHELLE PROEHL

	Name:	 	Steven J. Murphy	 	Name:	 	Michelle Proehl
	Title:	 	V.P. Finance and CFO	 	Title:	 	Assistant Vice President

  

 - 5 - 

 EXHIBIT B 
 FORM OF FINANCIAL COVENANT COMPLIANCE CERTIFICATE 
  

			
	TO:	  	 WELLS FARGO BANK, NATIONAL ASSOCIATION
(“BANK”)

		
		  	Bank under that certain Credit Agreement, dated as of January 4, 2006 (as amended, restated, modified and/or supplemented from time to time, the “Credit Agreement”),
between NATUS MEDICAL INCORPORATED, a Delaware corporation (the “Borrower”), and Bank.

 This Compliance Certificate is delivered this
             day of                     ,
20    , by the undersigned, as a senior financial officer of the Borrower to Bank in accordance with Section 5.3(f) of the Credit Agreement. 
 The undersigned hereby certifies that: 
 1. Attached hereto are the [consolidated annual audited] [consolidating quarterly unaudited] financial statements of the Borrower presented fairly in accordance with GAAP that are required to be delivered pursuant to
Section [5.3(a)] [5.3(b)] of the Credit Agreement for the period ending                     ,     
(the “End Date”). 
 2. As of the date of this Compliance Certificate, no Default or Event of Default had occurred and was
continuing. 
 3. The financial condition covenants and other compliance calculations and information set forth on Schedule 1
attached hereto are true, complete and accurate on and as of the date of this Compliance Certificate. 
 The foregoing certifications,
together with the computations set forth in Schedule 1 hereto, are made and delivered, and the financial statements referenced above are made or posted, as applicable, this
             day of                     ,
200    , pursuant to the provisions of the Credit Agreement. 
  

			
	By:	 	  

	Name:	 	  

	Title:	 	  

		 	of NATUS MEDICAL INCORPORATED

  

 B - 1 

 SCHEDULE 1 
 TO COMPLIANCE CERTIFICATE 
  

	A.	Leverage Ratio not greater than: 

  

	 	(i)	1.50 to 1.00 at each fiscal quarter end on or before 9/30/06 

  

	 	(ii)	1.00 to 1.00 at each fiscal quarter end after 9/30/06 

  

									
	1.	  	Adjusted Total Liabilities:	  			  		
		  	 a. all current liabilities
	  	$	                    	  		
		  	 b. plus all non-current liabilities
	  	$	                    	  		
		  	 c. minus Bio-logic DTL (relating to Base Date Bio-logic DTL, as defined in Credit Agreement)
	  	$	                    	  		
		  	 d. plus Natus DTA (as defined in Credit Agreement)
	  	$	                    	  		
		  	 e. Adjusted Total Liabilities (a+b-c+d):
	  			  	$	                    
	2.	  	 Adjusted Tangible Net Worth:
	  			  		
		  	 a. aggregate of total stockholders’ equity
	  	$	                    	  		
		  	 b. minus intangible assets
	  	$	                    	  		
		  	 c. plus $10,200,000
	  	$	10,200,000	  		
		  		  	 	 	  		
		  	 d. minus greater of (i) zero and (ii) the difference between the Base Date Bio-logic DTL and the current Bio-logic DTL (each as
defined in Credit Agreement)
	  	$	
                     
	  		
		  	 e. Adjusted Tangible Net Worth (a-b+c-d):
	  			  	$	                    
	3.	  	 Leverage Ratio (1.e. divided by 2.e.):
	  			  	 	                    
	4.	  	 In compliance (yes / no)?
	  			  	 	                    

  

	B.	Fixed Charge Coverage Ratio not less than: 

  

	 	(i)	3.00 to 1.00 as of each fiscal quarter on or before 9/30/06, determined on a rolling 4-quarter basis 

  

	 	(ii)	3.50 to 1.00 as of each fiscal quarter after 9/30/06, determined on a rolling 4-quarter basis 

  

									
	1.	  	NPAT:	  			  		
		  	a. net profit after taxes	  	$	                    	  		
		  	b. plus one-time restructuring charges related to Bio-logic acquisition, not to exceed $1,500,000	  	$	                    	  		
		  	c. plus write-offs of in-process research and development expenses associated with the acquisition of Bio-logic	  	$	
                     
	  		
		  	d. plus depreciation expense	  	$	                    	  		
		  	e. plus amortization expense	  	$	                    	  		
		  	f. NPAT (a+b+c+d+e)	  			  	$	                    
	2.	  	Aggregate of prior period CMLTD and capitalized lease payments	  			  		
		  	a. prior period current maturity of long-term debt	  			  		
		  	b. plus capitalized lease payments	  			  		
		  	c. Aggregate (a+b)	  			  	$	                    
	3.	  	Fixed Charge Coverage Ratio (1.f. divided by 2.c.):	  			  	 	                    
	4.	  	In compliance (yes / no)?	  			  	 	                    

  

 B - 2 

	C.	Liquidity not less than $8,000,000 as of each fiscal quarter end. 

  

									
	1.	  	Liquidity	  			  		
		  	a. unencumbered cash	  	$	                    	  		
		  	b. plus short-term marketable securities	  	$	                    	  		
	2.	  	Liquidity (1.a plus 1.b)	  			  	$	                    
	3.	  	In compliance (yes / no)?	  			  	 	                    

  

 B - 3 

 GUARANTOR’S CONSENT AND REAFFIRMATION 
 Each of the undersigned guarantors of all indebtedness of NATUS MEDICAL INCORPORATED, a Delaware corporation, to WELLS FARGO BANK, NATIONAL ASSOCIATION
hereby: (i) consents to the foregoing Second Amendment to Credit Agreement; (ii) reaffirms its obligations under its respective Continuing Guaranty; (iii) reaffirms its waivers of each and every one of the defenses to such obligations
as set forth in its respective Continuing Guaranty; and (iv) reaffirms that its obligations under its respective Continuing Guaranty are separate and distinct from the obligations of any other party under said Second Amendment to Credit
Agreement and the other Loan Documents described therein. 
  

			
	GUARANTOR:
	
	NATUS ACQUISITION CORPORATION
		
	By:	 	 /s/ STEVEN J. MURPHY

	Name:	 	 Steven J. Murphy

	Title:	 	 Chief Financial Officer

	
	BIO-LOGIC SYSTEMS CORP.
		
	By:	 	 /s/ STEVEN J. MURPHY

	Name:	 	 Steven J. Murphy

	Title:	 	 Chief Financial Officer

  

 B - 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]